NAVAMEDIC ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.1 NOK | -0.90% |
|
+1.53% | -9.81% |
| May. 06 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
| Apr. 30 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 53.2M | ||||||
| 684B | ||||||
| 568B | ||||||
| 361B | ||||||
| 329B | ||||||
| 284B |
- Stock Market
- Equities
- NAVA Stock
- Charts Navamedic ASA
- Sector Chart
